Back then, the nature of genes was a mystery, but the implication was clear – genetics can profoundly shape a person’s response to a drug. Pharmacogenomics today is a wide-ranging discipline ...

In this article, we review the pharmacogenomics of the drug efficacy of antidepressants in major depressive disorder. First, we survey the SNPs and genes identified as genetic markers that are ...

Growth Drivers of The Gene Therapy Industry As per IMARC, the US gene therapy market size has been pegged at US$1,312.2 million in 2024. The market should reach US$3,697.8 million by 2033.

Pharmacogenomics - tailoring drug treatments to individuals based on their genetics - is on the cusp of transforming drug ...